pool adsIshares Nasdaq Biotechnology E $IBB Technical Update
The Ishares Nasdaq Biotechnology E (NYSE: IBB) update and the technical summary table below can help you manage risk and optimize returns. We have day, swing, and longer-term trading plans for IBB, and 1300 other stocks too, updated in real time for our trial subscribers. The data below is a snapshot, but updates are available now.
Technical Summary
| Term → | Near | Mid | Long |
|---|---|---|---|
| Rating | Strong | Neutral | Neutral |
| P1 | 105.96 | 93.58 | 101.23 |
| P2 | 108.36 | 102.64 | 114.21 |
| P3 | 111.95 | 110.90 | 126.33 |
Support and Resistance Plot Chart for IBB
Long Term Trading Plans for IBB
December 6, 2018, 2:45 pm ET
The Technical Summary and Trading Plans for IBB help you determine where to buy, sell, and set risk controls. The data is best used in conjunction with our Market Analysis and Stock Correlation Filters too, because those help us go with the flow of the market as well. Going with the flow is extremely important, so review our Market Analysis with this IBB Report.
IBB - (Long) Support Plan
The technical summary data tells us to buy IBB near 101.23 with an upside target of 114.21. This data also tells us to set a stop loss @ 100.97 to protect against excessive loss in case the stock begins to move against the trade. 101.23 is the first level of support below 106.71 , and by rule, any test of support is a buy signal. In this case, support 101.23 would be being tested, so a buy signal would exist.
IBB - (Short) Resistance Plan
The technical summary data is suggesting a short of IBB as it gets near 114.21 with a downside target of 101.23. We should have a stop loss in place at 114.47 though. 114.21 is the first level of resistance above 106.71, and by rule, any test of resistance is a short signal. In this case, if resistance 114.21 is being tested, so a short signal would exist.
